---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-000550"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T15:59:43.734697+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Chromocell appoints Frank Knuettel as permanent CEO, removing interim status

## Summary
- Frank Knuettel appointed permanent CEO effective March 13, 2024; previously interim CEO since July 2023.
- Knuettel will continue as CFO, Treasurer, and Secretary of the company.
- He has raised over $300M in capital and managed 15+ M&A transactions during his career.
- Knuettel retains same compensation terms under existing amended consultant agreement.

## SEC filing metadata
- accession: 0001753926-24-000550
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392624000550/0001753926-24-000550-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392624000550/g084130_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-000550
- JSON: https://secwatch.observer/filing/0001753926-24-000550.json
- Plain text: https://secwatch.observer/filing/0001753926-24-000550.txt

## Key facts
- Executive change
  Francis Knuettel II was appointed as Chief Executive Officer at Pelthos Therapeutics Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: The board of directors (the “Board”) of Chromocell Therapeutics Corporation (the “Company”) has appointed Francis Knuettel II as Chief Executive Officer of the Company, effective March 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1919246/000175392624000550/0001753926-24-000550-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.